<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Induction of the p40/46 and p69/71 isoforms of the 2',5'-oligoadenylate (2-5A) synthetase by interferon-alpha (IFN-alpha) is variable among six different Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines with Ramos cells expressing among the highest levels of these enzymes </plain></SENT>
<SENT sid="1" pm="."><plain>Inhibitors of protein kinase C (PKC) block induction of <z:chebi fb="2" ids="33699">mRNAs</z:chebi> encoding both isoforms; however, induction of the p69/71 isoform is more sensitive to these inhibitors </plain></SENT>
<SENT sid="2" pm="."><plain>Down-regulation of PKC by prolonged treatment with 12-O-tetradecanoylphorbol-13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) also blocks induction of 2-5A synthetase <z:chebi fb="2" ids="33699">mRNAs</z:chebi> and decreases both constitutive and IFN-alpha-induced enzymatic activity </plain></SENT>
<SENT sid="3" pm="."><plain>Cotreatment of cells with <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> and IFN-alpha increases induction of 2-5A synthetase <z:chebi fb="2" ids="33699">mRNAs</z:chebi> above that seen in cells treated with IFN-alpha alone </plain></SENT>
<SENT sid="4" pm="."><plain>IFN-alpha does not directly activate PKC-alpha or PKC-delta, the two most abundant PKC isoforms present in Ramos cells, suggesting that PKC activation by another signaling pathway is necessary for maximal induction of 2-5A synthetases by IFN-alpha </plain></SENT>
</text></document>